Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
4DMedical Ltd ( (AU:4DX) ) just unveiled an update.
4DMedical Limited has applied to the ASX for quotation of a total of 413,652 new ordinary fully paid shares under its ticker 4DX, with 99,979 shares issued on 17 December 2025 and a further 313,673 shares issued on 18 December 2025. The additional securities, arising from the exercise or conversion of existing options or other convertible instruments, will expand the company’s issued capital base and may modestly enhance liquidity in its shares, signalling ongoing use of equity-based instruments in its capital management strategy.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited is an Australian-listed company on the ASX under the code 4DX. While this announcement does not provide operational detail, the company sits within the medical technology and diagnostics sector, focusing on healthcare-related products and services.
Average Trading Volume: 5,147,203
Technical Sentiment Signal: Buy
Current Market Cap: A$1.55B
For a thorough assessment of 4DX stock, go to TipRanks’ Stock Analysis page.